about
Macrophages and Uveitis in Experimental Animal ModelsReview: magnetic resonance imaging techniques in ophthalmology.Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapyIntravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in RatsUltrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis.Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.The role of TLR4 in photoreceptor {alpha}a crystallin upregulation during early experimental autoimmune uveitisInhibition of experimental autoimmune uveitis by amino acid copolymersUse of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.Cytokines in immunotherapy of experimental uveitis.Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis.Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.Epitopes and idiotypes in experimental autoimmune uveitis: a review.Macrophages in experimental autoimmune diseases in the rat: a review.Myopia and inflammationPhotodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisationPhotoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis.Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology.Angiographic abnormalities of experimental autoimmune uveoretinitis.Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis.Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia.Fundal white dots: the spectrum of a similar pathological process.Inflammatory choroidal neovascularization.Endogenous posterior uveitis.Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens.Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?SV40-immortalized and primary cultured human retinal pigment epithelial cells share similar patterns of cytokine-receptor expression and cytokine responsiveness.Retinal antigen-specific T cells mediate experimental autoimmune uveoretinitis (EAU) in PVG rat a model for tracking antigen-specific CD4(+) T cells in the inflamed eye.What determines the site of inflammation in uveitis and chorioretinitis?Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin ATotal dose and frequency of administration critically affect success of nasal mucosal tolerance induction.Identification of an S-antigen-like molecule in human choroid plexus and cerebrospinal fluid.Ciliary body in experimental autoimmune uveitis: tissue repair and immunoreactivity of extracellular matrix substances.Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.Effects of Japanese herbal medicine Sairei-to on murine experimental autoimmune uveitis.
P2860
Q26828497-2896BE54-664F-4312-949D-1CA79FBD5CAEQ27005563-089AF7BD-4700-4502-9059-C709D09F42B1Q28344712-7BFF9CBC-60AF-4F50-B5F5-CEDD6A4A57D1Q28565470-51BECD5E-BABF-4269-A023-383543C395FEQ33648840-ED6960A1-F09F-4DFE-B530-6B85C9A4D712Q33760317-CD72A2B0-DFE3-465D-B196-D7AA8D5C00D9Q33994219-45D923B1-45B2-486A-8E94-991C7E6C7F63Q34083323-0514E4ED-A0CC-4819-A533-B8BFD33B15A3Q34731124-D33B7DB1-0E1F-4FCA-AD06-54B35A26723FQ34981390-A506AC94-7E8F-4DCE-89FF-6195BD7BFBAAQ34993224-A0D5D211-BAD5-4EE9-A413-A317E34445C0Q35179369-CFAFDA90-BB1B-46E5-BB73-DC025DD6C594Q35309706-45AB801A-9EB1-4675-9D76-2FF17106BDB2Q35482896-BC9E48B5-E176-46C2-AD17-13C22DF179BCQ35482947-5C6825F9-CFF4-4D21-B3BB-569BC01E5E67Q35835600-C8FD29F1-720A-4B6D-AD9C-E5BEE43898EAQ35953670-944DCF82-CCE0-4BA1-855E-58437D0B51B2Q36014811-906FB2C7-C735-4B33-87D2-CB05A957AE53Q36765022-EF43B4F7-DBEC-481D-A35C-FB3412183E09Q36844742-02EC921D-3547-4BED-B8B8-AC62637323F0Q37229011-824476EC-BCFC-4F29-8B82-962FAF0115F6Q37308502-150C2090-B918-497B-B855-0963DE119D28Q37315195-50737910-043B-426D-8900-479FAD0D91E0Q37315262-B536ABE4-D688-4731-9417-ECA32F806B89Q37734236-8FFB3C71-3EEB-4524-B753-667E73BC1B3FQ38031601-9627AE9E-95EE-4807-81F1-74FAD80A6FC8Q39693140-2CA1EC91-B78F-44EB-808B-5FD3B1434E53Q39706642-4D4C6CFB-8A5F-4D56-AE45-BA3F46200880Q40094684-899ACBCD-42B4-49A1-95C7-47A4545C3F03Q40662599-5A7BD8CC-29DA-45AC-A052-96C30F6BB948Q40909960-79D04772-0203-44DC-9FDC-5B87A0B77832Q41342343-D80ACE00-4D7E-4820-A1CF-9469A75D3C6FQ41382365-4E3E0189-1357-4020-ACBA-91FF963FB445Q41625883-34D21F98-4BF9-400B-8AFB-8556B9CEAEDFQ41719098-58FDFB5D-DB88-468A-B55E-53B223871371Q41834495-739161FB-C601-4231-9297-0BD10D756A5AQ42144046-2B087BC5-13EC-472D-8D12-6190EE2EF503Q42457908-C9F451F2-563A-4238-AE7F-2A687D54FB34Q43225419-8821037B-9C71-4270-BD09-F61B5C81F27FQ45005198-B75F0B21-78FE-4ED8-A3EC-EE627581B7C4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of clinical and experimental uveitis.
@en
Comparison of clinical and experimental uveitis.
@nl
type
label
Comparison of clinical and experimental uveitis.
@en
Comparison of clinical and experimental uveitis.
@nl
prefLabel
Comparison of clinical and experimental uveitis.
@en
Comparison of clinical and experimental uveitis.
@nl
P2093
P2860
P1433
P1476
Comparison of clinical and experimental uveitis.
@en
P2093
Forrester JV
Liversidge J
McMenamin PG
P2860
P356
10.3109/02713689008999424
P478
P577
1990-01-01T00:00:00Z